Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Australian Clinical Labs Ltd ( (AU:ACL) ) has provided an update.
Allan Gray Australia Pty Ltd, an investment manager, has increased its voting power in Australian Clinical Labs Ltd from 9.90% to 10.95%. This change in substantial holding reflects a strategic move by Allan Gray Australia, potentially impacting the company’s governance and influencing its strategic direction.
The most recent analyst rating on (AU:ACL) stock is a Buy with a A$4.25 price target. To see the full list of analyst forecasts on Australian Clinical Labs Ltd stock, see the AU:ACL Stock Forecast page.
More about Australian Clinical Labs Ltd
Australian Clinical Labs Ltd operates in the healthcare industry, primarily providing pathology services. The company focuses on delivering diagnostic services across Australia, catering to a wide range of medical testing needs.
Average Trading Volume: 971,985
Technical Sentiment Signal: Sell
Current Market Cap: A$546M
See more data about ACL stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue